Sierra Capital’s Sanofi SNY Stock Holding History

Sierra Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,088	Closed	-$255K	–	714
2022 Q2	$255K	Hold	5,088	–	–	0.05%	173
2022 Q1	$261K	Hold	5,088	–	–	0.04%	181
2021 Q4	$255K	Sell	5,088 -32	-0.6%	-$1.58K	0.04%	196
2021 Q3	$247K	Hold	5,120	–	–	0.04%	178
2021 Q2	$270K	Hold	5,120	–	–	0.05%	157
2021 Q1	$253K	Buy	+5,120	New	+$246K	0.05%	159

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sierra Capital's SNY Position: Q3 2022 in Review

Sierra Capital sold out of Sanofi (SNY) in Q3 2022, closing a stake of 5,088 shares — an estimated $255K sold.

Sierra Capital first reported a position in SNY in Q1 2021 and held it in 6 quarters. The position peaked at $270K in Q2 2021. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Sierra Capital reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
Sierra Capital sold 5,088 Sanofi shares in Q3 2022, an estimated $255K.
Sierra Capital first reported a position in Sanofi in Q1 2021 and held it in 6 quarters.
Sierra Capital's Sanofi position peaked at $270K in Q2 2021.
587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Sierra Capital's 13F filing for Q3 2022, filed 4 Nov 2022.